Drug Shortage Report for RAN-GABAPENTIN
| Report ID | 19636 |
| Drug Identification Number | 02319055 |
| Brand name | RAN-GABAPENTIN |
| Common or Proper name | RAN-GABAPENTIN |
| Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-10-29 |
| Actual start date | 2018-10-29 |
| Estimated end date | 2019-01-15 |
| Actual end date | 2018-12-03 |
| Shortage status | Resolved |
| Updated date | 2019-02-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.